Innovative Cellular Therapeutics Holdings Ltd

Insider profile

Innovative Cellular Therapeutics Holdings Ltd's trades of Lyell Immunopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-20 2026-07-17 S Sale
1,057 +10.7%
168.74
US$1,676,035
1,057 +10.7% 168.74 US$1,676,035
2026-07-17 2026-07-16 S Sale
56,622 +32.2%
120.07
US$2,443,970
56,622 +32.2% 120.07 US$2,443,970